Bladder cancer
Results
Phase 2
This trial looked at gemcitabine and cisplatin alongside nintedanib for invasive bladder cancer.
This trial was open for people to join between 2014 and 2018. The team published the results in 2022.
Recruitment start: 4 December 2014
Recruitment end: 3 September 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Syed Hussain
Boehringer Ingelheim
Clatterbridge Cancer Centre NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Liverpool
Last reviewed: 21 January 2025
CRUK internal database number: 11977
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
